appropriate national government office of the host 
country is necessary. The NIH reserves the right to 
withhold funding if the safety practices employed 
abroad are not reasonably consistent with the NIH 
Guidelines . " 
Dr. Vidaver seconded the motion. 
Dr. Cohen asked if "in lieu of" could be substituted for "as 
evidence of" in the third paragraph. Mr. Brewer said he would 
accept this as a friendly amendment. Dr. Miller had the concern 
the term "collaboration" could be interpreted too broadly. He 
said scientists know what is meant by "collaboration," but 
thought some qualifying language needed to be added such as 
"active continual collaboration," to clarify the intent of the 
language. Mr. Brewer said he would drop the phrase "in 
collaboration with," if anyone had any wording that could better 
be substituted without raising ambiguities. 
Mr. Brell said an institution should bear the responsibility for 
monitoring to ensure the products of their research are not being 
used in a way that would contravene the provisions of the NIH 
Guidelines and the RAC was being too timid in their use of such 
words as "colla' oration. " He said he wanted the term 
"appropriate g rnment agency" defined. Mr. Brewer said he 
would be willi to accept expanded language similar to 
"appropriate national scientific or health official," if Mr. 
Brell thought that would clarify the issue. 
Dr. Riley asked if, in the case of a foreign country that did not 
have regulations in place, the only safeguard would be the 
signing-off by that country's government official. Dr. McGarrity 
explained the final sentence of I-C would still be in effect, 
that, "the NIH reserves the right to withhold funding" if the 
safety practices are not proper. 
Dr. Gottesman asked for clarification as to whether the current 
two sets of proposals differed so much from what appeared in the 
Federal Register notice that a vote would not be in order to 
approve either, and that it may have to be put out for public 
comment again. Mr. Lanman said he believed the proposal was now 
so broad that this was going to be necessary. Dr. Gottesman 
asked whether a vote should be taken to have one or the other 
proposals perfected and published for public comment. Dr. 
McKinney suggested the motions currently on the table be 
withdrawn. 
Mr. Brewer withdrew his motion from consideration at this time by 
the RAC. 
Dr. Tolin said she was in favor of the language being proposed. 
She cautioned that in adding requirements for compliance the 
Recombinant DNA Research, Volume 13 
[153] 
